Emerging trends of therapy related myeloid neoplasms following modern cancer therapeutics in the United States
Abstract Clonal hematopoiesis (CH) is a risk factor for the development of therapy-related myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML). Adoption of targeted-immunotherapeutics since 2011, may alter the risk of CH progression to tMDS/AML. To study this, we evaluated risk of tMD...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ad170899005a44ae897c0ca8999eacac |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|